Johnson & Johnson
JNJ
$166.61
$2.231.36%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 10/01/2023 | 07/02/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.13% | 10.57% | 6.46% | -1.36% | -6.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.13% | 10.57% | 6.46% | -1.36% | -6.63% |
| Cost of Revenue | 5.00% | 10.97% | 5.89% | -4.22% | -8.65% |
| Gross Profit | 5.19% | 10.40% | 6.72% | -0.06% | -5.71% |
| SG&A Expenses | 8.92% | 14.69% | 5.68% | -6.17% | -12.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.01% | 11.26% | 6.02% | -5.18% | -9.23% |
| Operating Income | 2.93% | 8.82% | 7.61% | 9.47% | 0.60% |
| Income Before Tax | 39.01% | 64.32% | -22.20% | -30.85% | -26.28% |
| Income Tax Expenses | 94.10% | 102.09% | -41.92% | -33.16% | -10.41% |
| Earnings from Continuing Operations | 31.88% | 59.11% | -18.59% | -30.53% | -27.93% |
| Earnings from Discontinued Operations | 3,323.42% | 2,377.31% | 4,849.43% | 14,902.03% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 191.24% | 202.39% | 95.94% | 80.74% | -28.92% |
| EBIT | 2.93% | 8.82% | 7.61% | 9.47% | 0.60% |
| EBITDA | 3.14% | 8.92% | 8.63% | 6.27% | -1.31% |
| EPS Basic | 201.67% | 211.61% | 100.96% | 86.94% | -28.40% |
| Normalized Basic EPS | 5.17% | 7.61% | 3.90% | 16.09% | 6.28% |
| EPS Diluted | 203.01% | 213.75% | 102.15% | 87.55% | -28.27% |
| Normalized Diluted EPS | 5.40% | 7.87% | 4.83% | 16.78% | 6.96% |
| Average Basic Shares Outstanding | -3.37% | -1.83% | -0.17% | -1.58% | -0.63% |
| Average Diluted Shares Outstanding | -3.67% | -2.16% | -1.08% | -2.12% | -1.20% |
| Dividend Per Share | 5.02% | 5.31% | 5.62% | 5.94% | 6.26% |
| Payout Ratio | -0.75% | -0.75% | -0.61% | -0.57% | 0.48% |
